首页 | 本学科首页   官方微博 | 高级检索  
     


The nucleotide receptor P2Y13 is a key regulator of hepatic High-Density Lipoprotein (HDL) endocytosis
Authors:S. Jacquet  C. Malaval  L. O. Martinez  K. Sak  C. Rolland  C. Perez  M. Nauze  E. Champagne  F. Tercé  C. Gachet  B. Perret  X. Collet  J.-M. Boeynaems  R. Barbaras
Affiliation:1. Dpt. Lipoprotéines et Médiateurs Lipidiques, INSERM U563, Bat. C, H?pital Purpan, 31024, Toulouse, cedex 03, France
2. Institute of Interdisciplinary Research, Free University of Brussels, 808 Route de Lennik, Brussels, 1070, Belgium
3. Laboratory of Medical Chemistry, Erasme Hospital, 808 Route de Lennik, Brussels, 1070, Belgium
4. Unité 311, Etablissement Francais du Sang-Alsace, 10 rue Spielmann, 67065, Strasbourg Cedex, France
Abstract:
Cell surface receptors for high-density lipoprotein (HDL) on hepatocytes are major partners in the regulation of cholesterol homeostasis. We recently identified a cell surface ATP synthase as a high-affinity receptor for HDL apolipoprotein A-I (apoA-I) on human hepatocytes. Stimulation of this ectopic ATP synthase by apoA-I triggered a low-affinity-receptor-dependent HDL endocytosis by a mechanism strictly related to the generation of ADP. This suggests that nucleotide G-protein- coupled receptors of the P2Y family are molecular components in this pathway. Only P2Y1 and P2Y13 are present on the membrane of hepatocytes. Using both a pharmacological approach and small interference RNA, we identified P2Y13 as the main partner in hepatic HDL endocytosis, in cultured cells as well as in situ in perfused mouse livers. We also found a new important action of the antithrombotic agent AR-C69931MX as a strong activator of P2Y13-mediated HDL endocytosis. Received 9 May 2005; received after revision 24 June 2005; accepted 1 September 2005
Keywords:HDL  lipoprotein receptors  nucleotide receptors  cholesterol  endocytosis
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号